A systematic review of miR-29 in cancer

JJ Kwon, TD Factora, S Dey, J Kota - Molecular Therapy-Oncolytics, 2019 - cell.com
MicroRNAs (miRNA) are small non-coding RNAs (∼ 22 nt in length) that are known as
potent master regulators of eukaryotic gene expression. miRNAs have been shown to play a …

New concepts in cancer biomarkers: circulating miRNAs in liquid biopsies

E Larrea, C Sole, L Manterola, I Goicoechea… - International journal of …, 2016 - mdpi.com
The effective and efficient management of cancer patients relies upon early diagnosis and/or
the monitoring of treatment, something that is often difficult to achieve using standard tissue …

The role of miR‐29 family in disease

M Horita, C Farquharson… - Journal of cellular …, 2021 - Wiley Online Library
MicroRNAs are small noncoding RNAs that can bind to the target sites in the 3'‐untranslated
region of messenger RNA to regulate posttranscriptional gene expression. Increasing …

Computational analysis of targeting SARS-CoV-2, viral entry proteins ACE2 and TMPRSS2, and interferon genes by host microRNAs

JB Pierce, V Simion, B Icli, D Perez-Cremades… - Genes, 2020 - mdpi.com
Rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus
responsible for coronavirus disease 2019 (COVID-19), has led to a global pandemic …

MicroRNA in leukemia: Tumor suppressors and oncogenes with prognostic potential

R Mardani, MH Jafari Najaf Abadi… - Journal of cellular …, 2019 - Wiley Online Library
Leukemia is known as a progressive malignant disease, which destroys the blood‐forming
organs and results in adverse effects on the proliferation and development of leukocytes and …

[HTML][HTML] miR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies

N Amodio, M Rossi, L Raimondi, MR Pitari, C Botta… - Oncotarget, 2015 - ncbi.nlm.nih.gov
A wealth of studies has highlighted the biological complexity of hematologic malignancies
and the role of dysregulated signal transduction pathways. Along with the crucial role of …

Strategies to modulate microRNA functions for the treatment of cancer or organ injury

TJ Lee, X Yuan, K Kerr, JY Yoo, DH Kim, B Kaur… - Pharmacological …, 2020 - ASPET
Cancer and organ injury—such as that occurring in the perioperative period, including acute
lung injury, myocardial infarction, and acute gut injury—are among the leading causes of …

The potential role of miR‐29 in health and cancer diagnosis, prognosis, and therapy

M Alizadeh, A Safarzadeh… - Journal of cellular …, 2019 - Wiley Online Library
Abstract miR‐29 family is one of the small noncoding RNAs and has a very important role in
many physiologic and pathologic functions through regulating the target genes that play …

MiR-29a: a potential therapeutic target and promising biomarker in tumors

J Wang, Q Zhang, D Wang, W Yan, H Sha… - Bioscience …, 2018 - portlandpress.com
MiRNAs, small non-coding RNA molecules, were recognized to be associated with the
incidence and development of diverse neoplasms. MiRNAs were small non-coding RNAs …

Role of microRNAs-29b-2,− 155,− 197 and− 205 as diagnostic biomarkers in serum of breast cancer females

O Shaker, M Maher, Y Nassar, G Morcos, Z Gad - Gene, 2015 - Elsevier
Micro-RNAs (miRs) are known to be differentially expressed in the serum of cancer patients
and controls, and can thus be used as biomarkers for cancer screening. We detected the …